- Home
- NCRA vs TLPH Comparison
NCRA vs TLPH Comparison
Compare NCRA & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- TLPH
- Stock Information
- Founded
- NCRA 2002
- TLPH 2005
- Country
- NCRA Taiwan
- TLPH United States
- Employees
- NCRA N/A
- TLPH N/A
- Industry
- NCRA Farming/Seeds/Milling
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- TLPH Health Care
- Exchange
- NCRA Nasdaq
- TLPH Nasdaq
- Market Cap
- NCRA 15.1M
- TLPH 11.1M
- IPO Year
- NCRA N/A
- TLPH 2011
- Fundamental
- Price
- NCRA $1.55
- TLPH $0.98
- Analyst Decision
- NCRA
- TLPH Strong Buy
- Analyst Count
- NCRA 0
- TLPH 1
- Target Price
- NCRA N/A
- TLPH $6.00
- AVG Volume (30 Days)
- NCRA 18.6K
- TLPH 7.3M
- Earning Date
- NCRA 11-13-2025
- TLPH 11-12-2025
- Dividend Yield
- NCRA N/A
- TLPH N/A
- EPS Growth
- NCRA N/A
- TLPH N/A
- EPS
- NCRA N/A
- TLPH N/A
- Revenue
- NCRA $13,865,984.00
- TLPH $27,000.00
- Revenue This Year
- NCRA N/A
- TLPH N/A
- Revenue Next Year
- NCRA N/A
- TLPH $14,533.26
- P/E Ratio
- NCRA N/A
- TLPH N/A
- Revenue Growth
- NCRA N/A
- TLPH N/A
- 52 Week Low
- NCRA $0.70
- TLPH $0.38
- 52 Week High
- NCRA $2.09
- TLPH $1.20
- Technical
- Relative Strength Index (RSI)
- NCRA 51.92
- TLPH 58.69
- Support Level
- NCRA $1.43
- TLPH N/A
- Resistance Level
- NCRA $1.60
- TLPH $1.20
- Average True Range (ATR)
- NCRA 0.10
- TLPH 0.12
- MACD
- NCRA -0.01
- TLPH 0.01
- Stochastic Oscillator
- NCRA 75.00
- TLPH 81.67
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.